ASH 2012 Interview with Dr. Rick Furman - CLL Support

CLL Support

22,369 members38,475 posts

ASH 2012 Interview with Dr. Rick Furman

bkoffman profile image
bkoffmanCLL CURE Hero
3 Replies

This is one of my favorite interviews as it tells the story of the phase 1 trials of ibrutinib and idelalisib (CAL 101) by Dr. Furman who was the investigator for them both. See bkoffman.blogspot.com

Written by
bkoffman profile image
bkoffman
CLL CURE Hero
To view profiles and participate in discussions please or .
Read more about...
3 Replies
Mikey47 profile image
Mikey47

Hi Brian,

Thanks for that.

Liked the Leonard Cohen at the IOW :) I saw him at the O2 centre in London a few years ago. He still has 'it' and it was a great show. Many other musicians there, including David Gilmour from Pink Floyd.

jangreen profile image
jangreen

Hi Its interesting to hear how important it is to listen to patients and their views when trying new drugs.

bkoffman profile image
bkoffmanCLL CURE Hero

@jangreen. Agreed. We all learn from each other.

You may also like...

ASH 2017: Dr. Richard Furman on the importance of MCL-1 in CLL (chronic lymphocytic leukemia)

used in combination with ibrutinib or rituximab. See this on the Murano trial from ASH 2017 that...

Dr. Furman on the Diminishing Role of FCR

text from Dr. Furman's post https://cllsociety.org/2017/12/one-mans-opinion-fcr-vs-ibrutinib/....

ASH 2012 Ibrutinib Press Conference

Patient Power Video...

ASH 2018: Dr. Kipps on antibodies and Venetoclax resistance

always continue to work. In the first part of my interview with Dr. Kipps at ASH 2018, he discusses...

My 1 year CAR-T anniversary and from ASH 2018, Dr. Siddiqi on how CLL treatment has changed.

https://cllsociety.org/2019/03/one-year-anniversary/ Also this week, I posted a brief ASH 2018...